25504-47-6

Usage

Uses

Used in Chemical Synthesis Industry:
Methyl 2-oxopiperidine-4-carboxylate is used as a chemical intermediate for the synthesis of other complex organic molecules. It plays a crucial role in the production of various compounds that may have applications in different fields, such as pharmaceuticals, materials science, or agrochemicals. The versatility of its structure allows for further functionalization and modification, making it a valuable building block in organic chemistry.

Upstream product

• 24537-50-6 (RS)-2-oxopiperidine-4-carboxylic acid 
• 77-78-1 dimethyl sulfate 
• 89937-77-9 methyl 2-oxo-1,2-dihydropyridine-4-carboxylate 
• 67-56-1 methanol 
• 22282-72-0 2-oxo-1,2-dihydropyridine-4-carboxylic acid 

Downstream Products

• 1313498-08-6 (+/-)-3-tert-butyl-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine 
• 1313498-17-7 LS⁽¹⁴⁶⁾N₂₈₁₇ 

Relevant academic research and scientific papers

Interrupted Pyridine Hydrogenation: Asymmetric Synthesis of δ-Lactams

Metal-catalyzed hydrogenation is an effective method to transform readily available arenes into saturated motifs, however, current hydrogenation strategies are limited to the formation of C?H and N?H bonds. The stepwise addition of hydrogen yields reactive unsaturated intermediates that are rapidly reduced. In contrast, the interruption of complete hydrogenation by further functionalization of unsaturated intermediates offers great potential for increasing chemical complexity in a single reaction step. Overcoming the tenet of full reduction in arene hydrogenation has been seldom demonstrated. In this work we report the synthesis of sought-after, enantioenriched δ-lactams from oxazolidinone-substituted pyridines and water by an interrupted hydrogenation mechanism.

METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH NEURODEGENERATIVE DISEASE

Provided herein are methods of treating cognitive impairment associated with neurodegenerative disease in a patient by administering to the patient an effective amount of the Compound, or a pharmaceutically acceptable salt thereof.

SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND METHODS OF USING SAME

Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders as well as other disorders.

An Efficient Two-Step Preparation of α-, β-, γ- or δ-Amino Acids from 2-Pyrazinones, 2-Hydroxypyrimidines or 2-Pyridones Respectively

A practical and efficient two-step procedure is reported for the preparation of a variety of α-, β-, γ- and δ-amino acids from 2-pyridone, 2-pyrazinone or 2-hydroxypyrimidine and derivatives. The procedure is amenable to scale-up and in most cases no chromatographic purification of the product is required. This approach is useful, especially in the synthesis of amino acids or deuterated amino acids that are not obtained by other methods.

SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME

Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.